Soyeong Lee

Key Market Access Projects (Completed)

DOPTELET (avatrombopag) – ITP

• Led end-to-end reimbursement listing, achieving NHIS listing within 11 months .
• Managed appraisal under a same-mechanism (TPO-RA) and competitive review environment , applying the weighted average price rule.
• Supported price negotiation with NHIS, securing access conditions sufficient to mitigate future price-cut risk and positioning the product above concurrently reviewed competitors .

EMPAVELI (pegcetacoplan) – PNH

• Led end-to-end reimbursement listing for a novel agent , achieving NHIS listing within 12 months .
• Addressed payer concerns related to incremental budget impact and supported import and listing of required medical devices via the NIDS program .

Ongoing Oncology Market Access Activities

• Supporting cost-effectiveness evaluation preparation for an oncology asset, including development of local economic evidence in collaboration with a partner company.
• Played a key role in strategic reassessment due to limitations in available clinical evidence, supporting a shift to supplementary evidence development and an alternative access pathway .

Additional Market Access Responsibilities

• Developed pricing and volume scenario analyses (PVA models) to support internal pricing strategy and negotiation planning.
• Conducted market access feasibility reviews for pipeline assets, assessing listing potential, pricing corridor, and access risks.
• Collaborated with Global Market Access, Medical, and Commercial teams to align local P&R strategy, value messaging, and global pricing governance.
• Participated in industry working groups (HIRA, KPBMA) to monitor market access policy and environmental changes.

• Reviewed pricing adjustment requests and reimbursement status changes.
• Managed reimbursement drug records, pricing data, and policy-related reviews.
• Supported Health Insurance Policy Deliberative Committee related to MoHW guideline revisions.

• Oncology pharmacy support, chemotherapy regimen review, and patient education.
• Experience provided foundational understanding of oncology pharmacotherapy.
• Mentored junior pharmacists to develop their clinical skills, fostering a supportive learning environment within the pharmacy team.
• Optimized inventory management to reduce waste and ensure timely availability of essential medications.